Close Menu
Innovation Village | Technology, Product Reviews, Business
    Facebook X (Twitter) Instagram
    Friday, October 10
    • About us
      • Authors
    • Contact us
    • Privacy policy
    • Terms of use
    • Advertise
    • Newsletter
    • Post a Job
    • Partners
    Facebook X (Twitter) LinkedIn YouTube WhatsApp
    Innovation Village | Technology, Product Reviews, Business
    • Home
    • Innovation
      • Products
      • Technology
      • Internet of Things
    • Business
      • Agritech
      • Fintech
      • Healthtech
      • Investments
        • Cryptocurrency
      • People
      • Startups
      • Women In Tech
    • Media
      • Entertainment
      • Gaming
    • Reviews
      • Gadgets
      • Apps
      • How To
    • Giveaways
    • Jobs
    Innovation Village | Technology, Product Reviews, Business
    You are at:Home»Acquisitions»Natco Pharma secures shareholder approval to acquire strategic stake in Adcock Ingram

    Natco Pharma secures shareholder approval to acquire strategic stake in Adcock Ingram

    0
    By Tapiwa Matthew Mutisi on October 10, 2025 Acquisitions, Business, Deals, Health

    India-listed pharmaceutical company Natco Pharma has received shareholder approval to acquire a significant minority stake in Adcock Ingram, a leading South African healthcare firm. The move marks a major step forward in Natco’s international expansion strategy and signals a new chapter for Adcock Ingram, which is set to be delisted from the Johannesburg Stock Exchange (JSE).

    Natco Pharma, known for its expertise in the research, development, manufacturing, and marketing of finished dosage formulations and active pharmaceutical ingredients, made a formal offer in July 2025 to acquire Adcock Ingram’s minority shareholders at R75 per share.

    Adcock Ingram is a household name in South Africa, manufacturing and distributing a wide range of healthcare products, including well-known brands such as Panado, Allergex, and Myprodol. The company has long operated under the majority control of Bidvest, which holds a 64.25% stake acquired in 2019.

    According to Sean Culverwell, Equity Analyst at Anchor Capital, the offer represented a strategic opportunity to resolve Adcock’s prolonged status in “minority purgatory.” With Bidvest’s dominant shareholding, free float liquidity had diminished, making a delisting increasingly likely.

    Upon completion of the transaction, Natco Pharma will hold a 35.75% stake in Adcock Ingram, valued at approximately R4 billion. Bidvest’s majority stake is excluded from the deal, and the group has opted to retain its position, which analysts view as a strategically sound decision given Adcock’s defensive earnings profile and diversified domestic operations.

    Culverwell noted that while Natco’s bid came as a surprise, it aligns with Bidvest’s broader strategy to prioritize capital allocation toward scaling its offshore services platform, with speculation around a potential unbundling of Bidcorp.

    The acquisition received overwhelming support at Adcock Ingram’s general meeting held on 9 October 2025, with 98.66% of scheme members voting in favour. The transaction is still subject to the waiver and fulfilment of outstanding conditions precedent, as outlined in the scheme circular.

    Once these conditions are met and the Takeover Regulation Panel issues a compliance certificate, Adcock Ingram’s shares will be delisted from the JSE Main Board. Shareholders recorded on the Scheme Record Date will receive the Per Share Scheme Consideration of R75.00. The final timeline for the implementation of the scheme and delisting will be announced in due course.

    Adcock Ingram Share Price

    Related

    Acquisition Adcock Ingram Africa Business deals health Healthcare Investments Natco Pharma Pharmaceutical Shareholder Approvals
    Share. Facebook Twitter Pinterest LinkedIn Email
    Tapiwa Matthew Mutisi
    • Facebook
    • X (Twitter)
    • LinkedIn

    Tapiwa Matthew Mutisi has been covering blockchain technology, intelligent technologies, cryptocurrency, cybersecurity, telecommunications technology, sustainability, autonomous vehicles, and other topics for Innovation Village since 2017. In the years since, he has published over 6,000 articles — a mix of breaking news, reviews, helpful how-tos, industry analysis, and more. | Open DM on Twitter @TapiwaMutisi

    Related Posts

    Uganda pilots CBDC as part of $5.5 billion tokenized economic transformation

    IHS Holding completes $274.5 million sale of Rwandan operations to Paradigm Tower Ventures

    How to Build Products That Solve Real Problems (And People Will Pay For)

    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    Copyright ©, 2013-2024 Innovation-Village.com. All Rights Reserved

    Type above and press Enter to search. Press Esc to cancel.

     

    Loading Comments...
     

    You must be logged in to post a comment.